Skip to the page

Data / Medical devices / Israel / Augma Biomaterials

Augma Biomaterials: FDA-registered device maker in Caesarea Southern Industrial Park Northern, Israel, 2 510(k) clearances

Augma Biomaterials is registered with the FDA (registration 3007490610) in Caesarea Southern Industrial Park Northern, Israel. It lists 1 device type. The FDA files 2 510(k) clearances under its listings, the newest dated December 5, 2013. Registered through 2027. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3007490610
Address
Alon Hatavor 20 St. P.O.Box 3089, Caesarea Southern Industrial Park Northern, Israel, 3088900
Owner or operator
Augma Biomaterials (10029027)
Roles
Manufacturer
First device listed
March 30, 2009
Registered through
2027
Brand names listed
3D Bond, 3D Bond+, Bond Apatite

Devices it lists

DeviceProduct codeClassRoleSource
Bone Grafting Material, SyntheticLYC2Manufactureraccessdata.fda.gov

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
December 5, 2013K121177BOND APATITELYCSubstantially EquivalentAugma Biomaterials, Ltd.accessdata.fda.gov
March 17, 2009K083858BOND BONELYCSubstantially EquivalentAugma Biomaterials, Ltd.accessdata.fda.gov

Compare with other makers

Updated December 5, 2013. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.